The healthcare landscape is seeing a development with the introduction of GLP-1 transdermal systems . These exciting formulations offer a possible approach to providing glucagon-like peptide-1 drugs for individuals battling the disease . Instead of injections , a simple patch applied to the skin could release a steady amount of the medication , pos